RESUMEN
Mastitis is a complex inflammatory disease caused by pathogenic infection of mammary tissue in dairy cows. The molecular mechanism behind its occurrence, development, and regulation consists of a multi-gene network including microRNA (miRNA). Until now, there is no report on the role of miR-125b in regulating mastitis in dairy cows. This study found that miR-125b expression is significantly decreased in lipopolysaccharide (LPS)-induced MAC-T bovine mammary epithelial cells. Also, its expression is negatively correlated with the expression of NF-κB inhibitor interacting Ras-like 2 (NKIRAS2) gene. MiR-125b target genes were identified using a double luciferase reporter gene assay, which showed that miR-125b can bind to the 3' untranslated region (3' UTR) of the NKIRAS2, but not the 3'UTR of the TNF-α induced protein 3 (TNFAIP3). In addition, miR-125b overexpression and silencing were used to investigate the role of miR-125b on inflammation in LPS-induced MAC-T. The results demonstrate that a reduction in miR-125b expression in LPS-induced MAC-T cells increases NKIRAS2 expression, which then reduces NF-κB activity, leading to low expression of the inflammatory factors IL-6 and TNF-α. Ultimately, this reduces the inflammatory response in MAC-T cells. These results indicate that miR-125b is a pro-inflammatory regulator and that its silencing can alleviate bovine mastitis. These findings lay a foundation for elucidating the molecular regulation mechanism of cow mastitis.
Asunto(s)
Proteínas Portadoras/genética , Enfermedades de los Bovinos/genética , Marcación de Gen/veterinaria , Inflamación/veterinaria , MicroARNs/genética , Animales , Proteínas Portadoras/metabolismo , Bovinos , Enfermedades de los Bovinos/inmunología , Línea Celular , Células Epiteliales/inmunología , Inflamación/genética , Inflamación/inmunología , MicroARNs/metabolismoRESUMEN
This study was conducted to investigate the effect of seven concentrations of Cas9 protein (0, 25, 50, 100, 200, 500, and 1,000 ng/µl) on the development and gene editing of porcine embryos. This included the target editing and off-target effect of embryos developed from zygotes that were edited via electroporation of the Cas9 protein with guide RNA targeting Myostatin genes. We found that the development to blastocysts of electroporated zygotes was not affected by the concentration of Cas9 protein. Although the editing rate, which was defined as the ratio of edited blastocysts to total examined blastocysts, did not differ with Cas9 protein concentration, the editing efficiency, which was defined as the frequency of indel mutations in each edited blastocyst, was significantly decreased in the edited blastocysts from zygotes electroporated with 25 ng/µl of Cas9 protein compared with that of blastocysts from zygotes electroporated with higher Cas9 protein concentrations. Moreover the frequency of indel events at the two possible off-target sites was not significantly different with different concentrations of Cas9 protein. These results indicate that the concentration of Cas9 protein affects gene editing efficiency in embryos but not the embryonic development, gene editing rate, and non-specific cleavage of off-target sites.
Asunto(s)
Proteína 9 Asociada a CRISPR , Electroporación/métodos , Electroporación/veterinaria , Desarrollo Embrionario/genética , Edición Génica , Marcación de Gen/veterinaria , Miostatina/genética , ARN Guía de Kinetoplastida , Porcinos/embriología , Porcinos/genética , Cigoto , Animales , Blastocisto , Proteína 9 Asociada a CRISPR/farmacología , Relación Dosis-Respuesta a DrogaRESUMEN
The CRISPR/Cas9 system now allows for unprecedented possibilities of genome editing. However, there are some limitations, including achieving efficient one-step multiple genome targeting to save costs, time, and ensure high quality. In the present study, we investigated the efficiency of one-step multiple gene modification by electroporation in porcine zygotes using pooled guide RNAs (gRNAs) targeting CMAH, GHR, GGTA1, and PDX1. We first selected the best-performing gRNA from three different designs for each gene based on the effect on embryo development and mutation efficiency. The three gRNAs showed equivalent effects on the rates of blastocyst formation in each targeted gene; however, gRNAs CMAH #2, GHR #3, GGTA1 #3, and PDX1 #3 showed the highest biallelic mutation rate, although the total mutation rate of PDX1 #3 was significantly lower than that of PDX1 #1. Therefore, CMAH #2, GHR #3, GGTA1 #3, and PDX1 #1 were used as a mixture in electroporation to further clarify whether multiple genes can be targeted simultaneously. Individual sequencing of 43 blastocysts at the target sites of each gene showed mutations in one and two target genes in twenty-four (55.8%) and nine (20.9%) blastocysts, respectively. No mutation was detected in any target gene in ten (23.3%) blastocysts and no blastocysts had a mutation in three or more target genes. These results indicate that electroporation could effectively deliver multiple gRNAs and Cas9 protein into porcine zygotes to target multiple genes in a one-step process. However, the technique requires further development to increase the success rate of multiple gene modification.
Asunto(s)
Sistemas CRISPR-Cas , Electroporación/métodos , Marcación de Gen/métodos , Porcinos/genética , Animales , Blastocisto/metabolismo , Células Cultivadas , Electroporación/veterinaria , Femenino , Fertilización In Vitro/métodos , Fertilización In Vitro/veterinaria , Galactosiltransferasas/genética , Marcación de Gen/veterinaria , Ghrelina/genética , Proteínas de Homeodominio/genética , Oxigenasas de Función Mixta/genética , ARN Guía de Kinetoplastida/genética , Porcinos/fisiología , Transactivadores/genética , Cigoto/metabolismoRESUMEN
Targeted knock-in (KI) can be achieved in embryos by clustered regularly interspaced short palindromic repeats (CRISPR)-assisted homology directed repair (HDR). However, HDR efficiency is constrained by the competition of nonhomologous end joining. The objective of this study was to explore whether CRISPR-assisted targeted KI rates can be improved in bovine embryos by exposure to the HDR enhancer RS-1. In vitro produced zygotes were injected with CRISPR components (300 ng/µl Cas9 messenger RNA and 100 ng/µl single guide RNA against a noncoding region) and a single-stranded DNA (ssDNA) repair template (100 ng/µl). ssDNA template contained a 6 bp XbaI site insert, allowing targeted KI detection by restriction analysis, flanked by 50 bp homology arms. Following microinjection, zygotes were exposed to 0, 3.75, or 7.5 µM RS-1 for 24 hr. No differences were noted between groups in terms of development or genome edition rates. However, targeted KI rates were doubled in the group exposed to 7.5 µM RS-1 compared to the others (52.8% vs. 25% and 23.1%, for 7.5, 0, and 3.75 µM, respectively). In conclusion, transient exposure to 7.5 µM RS-1 enhances targeted KI rates resulting in approximately half of the embryos containing the intended mutation, hence allowing direct KI generation in embryos.
Asunto(s)
Benzamidas/farmacología , Sistemas CRISPR-Cas/efectos de los fármacos , Bovinos/embriología , Reparación del ADN por Unión de Extremidades/efectos de los fármacos , Técnicas de Sustitución del Gen , Sulfonamidas/farmacología , Animales , Animales Modificados Genéticamente , Sistemas CRISPR-Cas/fisiología , Células Cultivadas , Roturas del ADN de Doble Cadena/efectos de los fármacos , Técnicas de Cultivo de Embriones , Embrión de Mamíferos , Edición Génica/métodos , Edición Génica/veterinaria , Técnicas de Sustitución del Gen/métodos , Técnicas de Sustitución del Gen/veterinaria , Marcación de Gen/métodos , Marcación de Gen/veterinariaRESUMEN
Spermatogonia represent a diploid germ cell population that includes spermatogonial stem cells. In this report, we describe new methods for isolation of highly enriched porcine spermatogonia based on light scatter properties, and for targeted mutagenesis in porcine spermatogonia using nucleofection and TALENs. We optimized a nucleofection protocol to deliver TALENs specifically targeting the DMD locus in porcine spermatogonia. We also validated specific sorting of porcine spermatogonia based on light scatter properties. We were able to obtain a highly enriched germ cell population with over 90% of cells being UCH-L1 positive undifferentiated spermatogonia. After gene targeting in porcine spermatogonia, indel (insertion or deletion) mutations as a result of non-homologous end joining (NHEJ) were detected in up to 18% of transfected cells. Our report demonstrates for the first time an approach to obtain a live cell population highly enriched in undifferentiated spermatogonia from immature porcine testes, and that gene targeting can be achieved in porcine spermatogonia which will enable germ line modification.
Asunto(s)
Marcación de Gen/veterinaria , Espermatogonias/metabolismo , Nucleasas de los Efectores Tipo Activadores de la Transcripción/genética , Animales , Edición Génica/veterinaria , Masculino , Espermatogénesis , Espermatogonias/citología , Porcinos , Testículo/metabolismo , Nucleasas de los Efectores Tipo Activadores de la Transcripción/metabolismoRESUMEN
The development of genome editing technology has allowed gene disruptions to be achieved in various animal species and has been beneficial to many mammals. Gene disruption using pluripotent stem cells is difficult to achieve in rabbits, but thanks to advances in genome editing technology, a number of gene disruptions have been conducted. This paper describes a simple and easy method for carrying out gene disruptions in rabbits using CRISPR/Cas9 in which the gene to be disrupted is marked, the presence or absence of off-target candidates is checked, and a plasmid allowing simultaneous expression of Cas9 and sgRNA is constructed. Next, the cleaving activity of candidate sequences is investigated, and assessments are carried out to determine whether the target sequences can be cut. Female rabbits subjected to superovulation treatment are mated with male rabbits and fertilized eggs are collected, and then pronuclear injection of plasmid DNA is performed. The next day, the two-cell stage embryos are transplanted into pseudopregnant rabbits, and offspring are born within approximately 29-30 days. The genomic DNA of the offspring is then examined to check what types of genetic modifications have occurred. With the advent of CRISPR/Cas9, the accessibility of gene disruptions in rabbits has improved remarkably. This paper summarizes specifically how to carry out gene disruptions in rabbits.
Asunto(s)
Sistemas CRISPR-Cas , Marcación de Gen/métodos , Microinyecciones/métodos , Animales , Femenino , Técnicas de Inactivación de Genes , Marcación de Gen/veterinaria , Vectores Genéticos/administración & dosificación , Microinyecciones/veterinaria , Plásmidos/genética , Conejos , Cigoto/crecimiento & desarrolloRESUMEN
The manipulation of the RNA interference pathway using small interfering RNA (siRNA) has become the most frequently used gene silencing method. However, siRNA delivery into primary cells, especially primary macrophages, is often considered challenging. Here we report the investigation of the suitability of two methodologies: transient transfection and electroporation, to deliver siRNA targeted against the putative immunomodulatory gene Mediterranean fever (MEFV) into primary bovine monocyte-derived macrophages (bMDM). Eleven commercial transfection reagents were investigated with variable results with respect to siRNA uptake, target gene knock-down, cell toxicity and type I interferon (IFN) response induction. Three transfection reagents: Lipofectamine 2000, Lipofectamine RNAiMAX and DharmaFECT 3, were found to consistently give the best results. However, all the transfection reagents tested induced an IFN response in the absence of siRNA, which could be minimized by reducing the transfection reagent incubation period. In addition, optimized siRNA delivery into bMDM by electroporation achieved comparable levels of target gene knock-down as transient transfection, without a detectable IFN response, but with higher levels of cell toxicity. The optimized transient transfection and electroporation methodologies may provide a starting point for optimizing siRNA delivery into macrophages derived from other species or other cells considered difficult to investigate with siRNA.
Asunto(s)
Electroporación/veterinaria , Macrófagos/inmunología , ARN Interferente Pequeño/administración & dosificación , ARN Interferente Pequeño/genética , Transfección/veterinaria , Animales , Bovinos , Proteínas del Citoesqueleto/genética , Proteínas del Citoesqueleto/inmunología , Femenino , Técnicas de Silenciamiento del Gen , Marcación de Gen/veterinaria , Pirina , Interferencia de ARNRESUMEN
Mastitis costs the dairy industry billions of dollars annually and is the most consequential disease of dairy cattle. Transgenic cows secreting an antimicrobial peptide demonstrated resistance to mastitis. The combination of somatic cell gene targeting and nuclear transfer provides a powerful method to produce transgenic animals. Recent studies found that a precisely placed double-strand break induced by engineered zinc-finger nucleases (ZFNs) stimulated the integration of exogenous DNA stretches into a pre-determined genomic location, resulting in high-efficiency site-specific gene addition. Here, we used ZFNs to target human lysozyme (hLYZ) gene to bovine ß-casein locus, resulting in hLYZ knock-in of approximately 1% of ZFN-treated bovine fetal fibroblasts (BFFs). Gene-targeted fibroblast cell clones were screened by junction PCR amplification and Southern blot analysis. Gene-targeted BFFs were used in somatic cell nuclear transfer. In vitro assays demonstrated that the milk secreted by transgenic cows had the ability to kill Staphylococcus aureus. We report the production of cloned cows carrying human lysozyme gene knock-in ß-casein locus using ZFNs. Our findings open a unique avenue for the creation of transgenic cows from genetic engineering by providing a viable tool for enhancing resistance to disease and improving the health and welfare of livestock.
Asunto(s)
Caseínas/genética , Resistencia a la Enfermedad/genética , Marcación de Gen/veterinaria , Mastitis Bovina/genética , Muramidasa/genética , Dedos de Zinc/genética , Animales , Secuencia de Bases , Bovinos , Clonación de Organismos/veterinaria , Femenino , Fibroblastos/enzimología , Genes Reporteros , Genómica , Humanos , Mastitis Bovina/prevención & control , Datos de Secuencia Molecular , Técnicas de Transferencia Nuclear/veterinaria , Organismos Modificados Genéticamente , Alineación de SecuenciaRESUMEN
The establishment of embryonic stem cells (ESCs) and gene targeting technologies in mice has revolutionised the field of genetics. The relative ease with which genes can be knocked out, and exogenous sequences introduced, has allowed the mouse to become the prime model for deciphering the genetic code. Not surprisingly, the lack of authentic ESCs has hampered the livestock genetics field and has forced animal scientists into adapting alternative technologies for genetic engineering. The recent discovery of the creation of induced pluripotent stem cells (iPSCs) by upregulation of a handful of reprogramming genes has offered renewed enthusiasm to animal geneticists. However, much like ESCs, establishing authentic iPSCs from the domestic animals is still beset with problems, including (but not limited to) the persistent expression of reprogramming genes and the lack of proven potential for differentiation into target cell types both in vitro and in vivo. Site-specific nucleases comprised of zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regulated interspaced short palindromic repeats (CRISPRs) emerged as powerful genetic tools for precisely editing the genome, usurping the need for ESC-based genetic modifications even in the mouse. In this article, in the aftermath of these powerful genome editing technologies, the role of pluripotent stem cells in livestock genetics is discussed.
Asunto(s)
Animales Modificados Genéticamente , Reprogramación Celular , Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas , Desoxirribonucleasas/metabolismo , Ingeniería Genética/veterinaria , Células Madre Pluripotentes Inducidas/metabolismo , Ganado/genética , Ribonucleasas/metabolismo , Factores de Transcripción/metabolismo , Animales , Línea Celular , Desoxirribonucleasas/genética , Regulación del Desarrollo de la Expresión Génica , Marcación de Gen/veterinaria , Técnicas de Transferencia de Gen/veterinaria , Genotipo , Fenotipo , Ribonucleasas/genética , Factores de Transcripción/genéticaRESUMEN
Over the past 5 years there has been a major transformation in our ability to precisely manipulate the genomes of animals. Efficiencies of introducing precise genetic alterations in large animal genomes have improved 100000-fold due to a succession of site-specific nucleases that introduce double-strand DNA breaks with a specificity of 10(-9). Herein we describe our applications of site-specific nucleases, especially transcription activator-like effector nucleases, to engineer specific alterations in the genomes of pigs and cows. We can introduce variable changes mediated by non-homologous end joining of DNA breaks to inactive genes. Alternatively, using homology-directed repair, we have introduced specific changes that support either precise alterations in a gene's encoded polypeptide, elimination of the gene or replacement by another unrelated DNA sequence. Depending on the gene and the mutation, we can achieve 10%-50% effective rates of precise mutations. Applications of the new precision genetics are extensive. Livestock now can be engineered with selected phenotypes that will augment their value and adaption to variable ecosystems. In addition, animals can be engineered to specifically mimic human diseases and disorders, which will accelerate the production of reliable drugs and devices. Moreover, animals can be engineered to become better providers of biomaterials used in the medical treatment of diseases and disorders.
Asunto(s)
Animales Modificados Genéticamente , Bovinos/genética , Reprogramación Celular , Desoxirribonucleasas/metabolismo , Ingeniería Genética/veterinaria , Genoma , Ribonucleasas/metabolismo , Sus scrofa/genética , Factores de Transcripción/metabolismo , Animales , Desoxirribonucleasas/genética , Regulación del Desarrollo de la Expresión Génica , Marcación de Gen/veterinaria , Genotipo , Fenotipo , Ribonucleasas/genética , Factores de Transcripción/genéticaRESUMEN
The macrolide class of antibiotics, including tylosin and tilmicosin, is widely used in the veterinary field for prophylaxis and treatment of mycoplasmosis. In vitro susceptibility testing of 50 strains of M. gallisepticum isolated in Israel during the period 1997-2010 revealed that acquired resistance to tylosin as well as to tilmicosin was present in 50% of them. Moreover, 72% (13/18) of the strains isolated from clinical samples since 2006 showed acquired resistance to enrofloxacin, tylosin and tilmicosin. Molecular typing of the field isolates, performed by gene-target sequencing (GTS), detected 13 molecular types (I-XIII). Type II was the predominant type prior to 2006 whereas type X, first detected in 2008, is currently prevalent. All ten type X strains were resistant to both fluoroquinolones and macrolides, suggesting selective pressure leading to clonal dissemination of resistance. However, this was not a unique event since resistant strains with other GTS molecular types were also found. Concurrently, the molecular basis for macrolide resistance in M. gallisepticum was identified. Our results revealed a clear-cut correlation between single point mutations A2058G or A2059G in domain V of the gene encoding 23S rRNA (rrnA, MGA_01) and acquired macrolide resistance in M. gallisepticum. Indeed, all isolates with MIC ≥ 0.63 µg/mL to tylosin and with MIC ≥ 1.25 µg/mL to tilmicosin possess one of these mutations, suggesting an essential role in decreased susceptibility of M. gallisepticum to 16-membered macrolides.
Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple , Fluoroquinolonas/farmacología , Infecciones por Mycoplasma/veterinaria , Mycoplasma gallisepticum/efectos de los fármacos , Enfermedades de las Aves de Corral/epidemiología , Tilosina/farmacología , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Enrofloxacina , Marcación de Gen/veterinaria , Genes Bacterianos , Israel/epidemiología , Pruebas de Sensibilidad Microbiana/veterinaria , Datos de Secuencia Molecular , Tipificación Molecular/veterinaria , Infecciones por Mycoplasma/epidemiología , Infecciones por Mycoplasma/microbiología , Mycoplasma gallisepticum/genética , Filogenia , Reacción en Cadena de la Polimerasa/veterinaria , Enfermedades de las Aves de Corral/microbiología , ARN Ribosómico 23S/genética , ARN Ribosómico 23S/metabolismo , Proteínas Ribosómicas/genética , Proteínas Ribosómicas/metabolismo , Estaciones del Año , Tilosina/análogos & derivadosRESUMEN
Animals with a targeted disruption of genes can be produced by somatic cell nuclear transfer (SCNT). However, difficulties in clonal selection of somatic cells with a targeted mutation often result in heterogeneous nuclear donor cells, including gene-targeted and non-targeted cells, and impose a risk of producing undesired wildtype cloned animals after SCNT. In addition, the efficiency of cloning by SCNT has remained extremely low. Most cloned embryos die in utero, and the few that develop to term show a high incidence of postnatal death and abnormalities. In the present study, resurrection of an alpha-1,3-galactosyltransferase (αGT) gene-targeted miniature pig by recloning using postmortem ear skin fibroblasts was attempted. Three cloned piglets were produced from the first round of SCNT, including one stillborn and two who died immediately after birth due to respiratory distress syndrome and cardiac dysfunction. Among the three piglets, two were confirmed to be αGT gene-targeted. Fibroblasts derived from postmortem ear skin biopsies were used as nuclear donor cells for the second round of SCNT, and a piglet was produced. As expected, PCR and Southern analyses confirmed that the piglet produced from recloning was αGT gene-targeted. Currently, the piglet is fourteen months of age, and no overt health problems have been observed. Results from the present study demonstrate that loss of an invaluable animal, such as a gene-targeted miniature pig, may be rescued by recloning, with assurance of the desired genetic modification.
Asunto(s)
Clonación de Organismos/veterinaria , Galactosiltransferasas/genética , Técnicas de Transferencia Nuclear/veterinaria , Porcinos Enanos , Animales , Southern Blotting/veterinaria , Clonación de Organismos/métodos , Oído , Transferencia de Embrión/veterinaria , Femenino , Fibroblastos/ultraestructura , Marcación de Gen/veterinaria , Oocitos/fisiología , Oocitos/ultraestructura , Reacción en Cadena de la Polimerasa/veterinaria , Embarazo , PorcinosRESUMEN
Human babies and other young mammals prefer food odours and flavours of their mother's diet during pregnancy as well as their mother's individually distinctive odour. Newborn mice also prefer the individual odours of more closely related--even unfamiliar--lactating females. If exposure to in utero odorants-which include metabolites from the mother's diet and the foetus's genetically determined individual odour-helps shape the neuroanatomical development of the olfactory bulb, this could influence the perception of such biologically important odours that are preferred after birth. We exposed gene-targeted mice during gestation and nursing to odorants that activate GFP-tagged olfactory receptors (ORs) and then measured the effects on the size of tagged glomeruli in the olfactory bulb where axons from olfactory sensory neurons (OSNs) coalesce by OR type. We found significantly larger tagged glomeruli in mice exposed to these activating odorants in amniotic fluid, and later in mother's milk, as well as significant preferences for the activating odour. Larger glomeruli comprising OSNs that respond to consistently encountered odorants should enhance detection and discrimination of these subsequently preferred odours, which in nature would facilitate selection of palatable foods and kin recognition, through similarities in individual odours of relatives.
Asunto(s)
Lactancia , Odorantes/análisis , Bulbo Olfatorio/fisiología , Neuronas Receptoras Olfatorias/fisiología , Preñez , Efectos Tardíos de la Exposición Prenatal/veterinaria , Animales , Conducta Animal , Femenino , Marcación de Gen/veterinaria , Ratones , Bulbo Olfatorio/anatomía & histología , Bulbo Olfatorio/crecimiento & desarrollo , Neuronas Receptoras Olfatorias/citología , Neuronas Receptoras Olfatorias/crecimiento & desarrollo , Embarazo , Efectos Tardíos de la Exposición Prenatal/metabolismo , Receptores Odorantes/genética , Receptores Odorantes/metabolismo , DesteteRESUMEN
The swamp buffalo holds tremendous potential in the livestock sector in Asian and Mediterranean countries. Current needs are the faster multiplication of superior genotypes and the conservation of endangered buffalo breeds. Recent advances in assisted reproductive technologies, including in vitro embryo production methodologies, offer enormous opportunities to not only improve productivity, but also to use buffaloes to produce novel products for applications to human health and nutrition. The use of molecular genomics will undoubtedly advance these technologies for their large-scale application and resolve the key problems currently associated with advanced reproductive techniques, such as animal cloning, stem cell technology and transgenesis. Preliminary success in the application of modern reproductive technologies warrants further research at the cellular and molecular levels before their commercial exploitation in buffalo breeding programmes.
Asunto(s)
Búfalos/fisiología , Preñez , Técnicas Reproductivas/veterinaria , Animales , Animales Modificados Genéticamente , Búfalos/embriología , Búfalos/genética , Clonación Molecular , Criopreservación/veterinaria , Técnicas de Cultivo de Embriones/veterinaria , Transferencia de Embrión/veterinaria , Células Madre Embrionarias/fisiología , Femenino , Marcación de Gen/veterinaria , Genómica , Masculino , Técnicas de Transferencia Nuclear/veterinaria , Recuperación del Oocito/veterinaria , Inducción de la Ovulación/veterinaria , Embarazo , Técnicas Reproductivas/tendencias , Preselección del Sexo/veterinariaRESUMEN
The gene targeting combined somatic cell nuclear transfer is very useful in agriculture and medicine. Epigenetic modification of DNA by methylation is significant in regulating gene expression during mammalian development. During gene targeting, epigenetic status of donor cell nuclei may be changed in a series of processes, including homologous recombination, cell selection and cloning. We examined DNA methylation of six genes (beta-actin, VEGF, oct4, TERT, H19 and Igf2) and a repetitive sequence art2 in blg(+/-) cell line from beta-lactoglobulin (BLG) gene targeted fetus and the cells used for BLG gene targeting serve as control. The results demonstrated that the widespread changes of DNA methylation were found in blg(+/-) cell line. But the degree of variation was different. DNA methylation of VEGF in blg(+/-) was noticeably decreased. These observations suggest that DNA methylation variations may impact gene expression and finally induce abnormalities and lethality in later developmental stages.
Asunto(s)
Línea Celular , Metilación de ADN , Feto/citología , Marcación de Gen , Lactoglobulinas/genética , ADP Ribosa Transferasas/genética , Animales , Animales Modificados Genéticamente , Bovinos , Islas de CpG , Metilación de ADN/fisiología , Feto/metabolismo , Regulación del Desarrollo de la Expresión Génica , Marcación de Gen/métodos , Marcación de Gen/veterinaria , Factor II del Crecimiento Similar a la Insulina/genética , Lactoglobulinas/metabolismo , Factor 3 de Transcripción de Unión a Octámeros/genética , ARN Largo no Codificante , ARN no Traducido/genética , Telomerasa/genética , Factor A de Crecimiento Endotelial Vascular/genéticaRESUMEN
The targeted RNA recombination was attempted to substitute the membrane (M) protein gene and part of the nucleocapsid (N) protein gene of mouse hepatitis virus with the corresponding sequences from bovine coronavirus. Using a defective interfering (DI) RNA-like cDNA construct derived from pMH54, 690 nucleotides representing the entire M gene and the 5' most 915 nucleotides of the N gene of the mouse hepatitis virus Albany 4 mutant were attempted to be replaced. Upon infection of cells with Albany 4 followed by transfection with synthetic RNA transcribed from the DI-like cDNA construct, recombinant mouse hepatitis viruses as the large plaque forming phenotype were isolated by plaque assays at the non-permissive temperature of 391 degrees C. By RT-PCR and sequencing, those large plaque phenotypes were confirmed to have contained the thermostable phenotype marker derived from the transfected RNA, demonstrating that recombination occurred between the Albany 4 genomic RNA and the in vitro RNA transcripts. Further analysis of the recombinant viruses indicated that there combination had taken place within the region of 222 nucleotides between positions 916 and 1,137 of the N gene. This is the region immediately downstream of the replacement sequence and the start of the temperature resistant phenotype marker. The results suggest that the M and part of the N genes of bovine coronavirus may not be able to complement the function of those of mouse hepatitis virus. This study redirects our current approach of utilizing the MHV targeted RNA recombination as a means to study bovine coronavirus genetics towards the construction of an infectious cDNA clone.
Asunto(s)
Coronavirus Bovino/genética , Virus de la Hepatitis Murina/genética , Proteínas de la Nucleocápside/genética , ARN Viral/genética , Proteínas de la Matriz Viral/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Bovinos , Células Cultivadas , ADN Complementario/genética , Marcación de Gen/veterinaria , Vectores Genéticos , Ratones , Datos de Secuencia Molecular , Fenotipo , ARN Viral/química , ARN Viral/aislamiento & purificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/veterinaria , Homología de Secuencia de Aminoácido , Transfección/veterinaria , Ensayo de Placa Viral/veterinariaRESUMEN
The targeted RNA recombination was attempted to substitute the membrane (M) protein gene and part of the nucleocapsid (N) protein gene of mouse hepatitis virus with the corresponding sequences from bovine coronavirus. Using a defective interfering (DI) RNA-like cDNA construct derived from pMH54, 690 nucleotides representing the entire M gene and the 5' most 915 nucleotides of the N gene of the mouse hepatitis virus Albany 4 mutant were attempted to be replaced. Upon infection of cells with Albany 4 followed by transfection with synthetic RNA transcribed from the DI-like cDNA construct, recombinant mouse hepatitis viruses as the large plaque forming phenotype were isolated by plaque assays at the non-permissive temperature of 391 degrees C. By RT-PCR and sequencing, those large plaque phenotypes were confirmed to have contained the thermostable phenotype marker derived from the transfected RNA, demonstrating that recombination occurred between the Albany 4 genomic RNA and the in vitro RNA transcripts. Further analysis of the recombinant viruses indicated that there combination had taken place within the region of 222 nucleotides between positions 916 and 1,137 of the N gene. This is the region immediately downstream of the replacement sequence and the start of the temperature resistant phenotype marker. The results suggest that the M and part of the N genes of bovine coronavirus may not be able to complement the function of those of mouse hepatitis virus. This study redirects our current approach of utilizing the MHV targeted RNA recombination as a means to study bovine coronavirus genetics towards the construction of an infectious cDNA clone.